ABELES JOHN H purchased 20.5% of their position (266.67K shares) of MEDITE CANCER DIAGNOSTICS, INC. on the open market
Open‑market purchase worth $20.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/23/2018ACC: 0001415889-18-001538
Director
Since Jul 2018
+306.67K
Net shares
Net buyer
$20.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
306.67K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+40K
Price / share
—
Trade value
—
% of position
3.2%
8/13/2018
1.26M→1.30M
Common Stock
Indirect
Shares
+266.67K
Price / share
$0.07
Trade value
$20K
% of position
20.5%
10/11/2018
1.30M→1.57M
Total
Net shares
+306.67K
Net value
$20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/13/2018 | J · J | +40K | — | — | 3.2% | 1.26M | 1.30M |
| Common Stock Indirect | 10/11/2018 | P · Purchase | +266.67K | $0.07 | $20K | 20.5% | 1.30M | 1.57M |
| Total | +306.67K | $20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned116.35K
Total
116.35K direct116.35K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 116.35K | Direct |
| Total | 116.35K | 116.35K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported